139 related articles for article (PubMed ID: 2959490)
21. Centrally mediated inhibitory effect of 5-[2-(diethylamino)ethyl]amino-5,11-dihydro[1]benzoxepino[3,4- b]pyridine trihydrochloride (KW-5805) on gastric acid secretion in rats.
Yano S; Kimura Y; Horie S; Ito K; Yamada N; Mizuno M; Watanabe K
Jpn J Pharmacol; 1990 Feb; 52(2):287-93. PubMed ID: 2313937
[TBL] [Abstract][Full Text] [Related]
22. Effect of vagotomy on brain and plasma atrial natriuretic peptide during hemorrhage.
Phillips MI; Kimura B; Wang H; Hoffman WE
Am J Physiol; 1989 Dec; 257(6 Pt 2):R1393-9. PubMed ID: 2532480
[TBL] [Abstract][Full Text] [Related]
23. Antidipsogenic action of a novel peptide, 'brain natriuretic peptide', in rats.
Itoh H; Nakao K; Yamada T; Shirakami G; Kangawa K; Minamino N; Matsuo H; Imura H
Eur J Pharmacol; 1988 May; 150(1-2):193-6. PubMed ID: 2969822
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of growth hormone secretion by central administration of atrial natriuretic polypeptide in the rat.
Murakami Y; Kato Y; Tojo K; Inoue T; Yanaihara N; Imura H
Endocrinology; 1988 May; 122(5):2103-8. PubMed ID: 2966063
[TBL] [Abstract][Full Text] [Related]
25. Brain vasoactive intestinal peptide: a potent stimulant of gastric acid secretion.
Hernandez DE; Jennes C; Emerick SG
Brain Res; 1987 Sep; 420(1):129-34. PubMed ID: 3676748
[TBL] [Abstract][Full Text] [Related]
26. Regulatory role of atrial natriuretic polypeptide in water drinking in rats.
Katsuura G; Nakamura M; Inouye K; Kono M; Nakao K; Imura H
Eur J Pharmacol; 1986 Feb; 121(2):285-7. PubMed ID: 2938978
[TBL] [Abstract][Full Text] [Related]
27. C-type natriuretic peptide applied to the brain enhances exocrine pancreatic secretion through a vagal pathway.
Sabbatini ME; RodrÃguez MR; Corbo NS; Vatta MS; Bianciotti LG
Eur J Pharmacol; 2005 Nov; 524(1-3):67-74. PubMed ID: 16263110
[TBL] [Abstract][Full Text] [Related]
28. Morphine reduces vagal-stimulated gastric acid secretion through a central action.
Ho MM; Dai S; Ogle CW
Eur J Pharmacol; 1987 Jul; 139(3):251-7. PubMed ID: 3666004
[TBL] [Abstract][Full Text] [Related]
29. Central effect of atrial natriuretic polypeptide on angiotensin II-stimulated vasopressin secretion in conscious rats.
Yamada T; Nakao K; Morii N; Itoh H; Shiono S; Sakamoto M; Sugawara A; Saito Y; Ohno H; Kanai A
Eur J Pharmacol; 1986 Jun; 125(3):453-6. PubMed ID: 2942414
[TBL] [Abstract][Full Text] [Related]
30. Central site of inhibitory action of bombesin on gastric acid secretion in rats.
Okuma Y; Yokotani K; Osumi Y
Jpn J Pharmacol; 1987 Oct; 45(2):129-33. PubMed ID: 3437584
[TBL] [Abstract][Full Text] [Related]
31. Effects of natriuretic peptides on the centrally mediated pressor response to clonidine in freely moving rats.
Nakamura S; Kawasaki H; Takasaki K
Jpn J Pharmacol; 1991 Nov; 57(3):443-6. PubMed ID: 1839909
[TBL] [Abstract][Full Text] [Related]
32. Sympatho-adrenomedullary system mediation of the bombesin-induced central inhibition of gastric acid secretion.
Okuma Y; Yokotani K; Osumi Y
Eur J Pharmacol; 1987 Jul; 139(1):73-8. PubMed ID: 3115795
[TBL] [Abstract][Full Text] [Related]
33. Recombinant interleukin-1 beta inhibits gastric acid secretion by activation of central sympatho-adrenomedullary outflow in rats.
Yokotani K; Okuma Y; Osumi Y
Eur J Pharmacol; 1995 Jun; 279(2-3):233-9. PubMed ID: 7556406
[TBL] [Abstract][Full Text] [Related]
34. A comparison of synthetic human and rat ANP administered intracerebroventricularly in freely moving normotensive and hypertensive rats.
Squadrito F; Frisina N; Buemi M; Sturniolo R; Autolitano A; Magri V; Squadrito G; Caputi AP
J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S27-30. PubMed ID: 2473344
[TBL] [Abstract][Full Text] [Related]
35. [Mechanism of effect of intraventricular administration of histamine H1-receptor agonists on gastric acid secretion in rats].
Sun CG; Wang ZL; Wang TZ; Lu GQ
Sheng Li Xue Bao; 1993 Dec; 45(6):581-6. PubMed ID: 8146684
[TBL] [Abstract][Full Text] [Related]
36. Diuretic and natriuretic action of rat atrial natriuretic peptide (6-33) administered intracerebroventricularly in rats.
Israel A; Barbella Y
Brain Res Bull; 1986 Aug; 17(2):141-4. PubMed ID: 2945621
[TBL] [Abstract][Full Text] [Related]
37. Suppression of luteinizing hormone secretion by atrial and brain natriuretic peptides in ovariectomized rats.
Zhang J; Yuen BH; Currie WD; Leung PC
Endocrinology; 1991 Aug; 129(2):801-6. PubMed ID: 1830270
[TBL] [Abstract][Full Text] [Related]
38. Atrial natriuretic factor-induced vasodepression occurs through central nervous system.
Levin ER; Weber MA; Mills S
Am J Physiol; 1988 Sep; 255(3 Pt 2):H616-22. PubMed ID: 2970804
[TBL] [Abstract][Full Text] [Related]
39. Evidence for an involvement of dopamine receptors in the natriuretic response to atrial natriuretic peptide.
Marin-Grez M; Angchanpen P; Gambaro G; Schnermann J; Schubert G; Briggs JP
Klin Wochenschr; 1987; 65 Suppl 8():97-102. PubMed ID: 2955166
[TBL] [Abstract][Full Text] [Related]
40. C-type natriuretic peptide mediates the hypothalamic actions of the natriuretic peptides to inhibit luteinizing hormone secretion.
Samson WK; Huang FL; Fulton RJ
Endocrinology; 1993 Feb; 132(2):504-9. PubMed ID: 8425472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
